Praxis Precision Medicines, Inc.

PRAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689548

Price chart

Open-market purchases and sales by PRAX insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Jun 26, 2026Jun 24, 2026DeSimone JillDirectorSSaleCommon Stock−11.6K$311.3209−$3.61M2.34K−83.2%SEC10b5-1
Nov 21, 2025Nov 20, 2025Nemiroff AlexGeneral Counsel and SecretarySSaleCommon Stock−25.13K$193.0843−$4.85M20.83K−54.7%SEC
Nov 21, 2025Nov 20, 2025Mastrocola LaurenPrincipal Accounting OfficerSSaleCommon Stock−13.6K$192.0783−$2.61M10.44K−56.6%SEC
Oct 17, 20254:10 PM ETOct 16, 2025Atchinson Robert and 2 others10% OwnerSSaleCommon Stock, $0.0001 par value per share ("Common Stock")+12.6K$90.0025+$1.13M2.36M+0.5%SEC
Oct 17, 20254:10 PM ETOct 16, 2025Atchinson Robert and 2 others10% OwnerSSaleCommon Stock+301.31K$106.4156+$32.06M2.06M+17.1%SEC

The largest institutional positions in PRAX at the end of Q2 2026.

Institutions holding PRAX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Jupiter Topco LLC3,421,374$1.15B0.47%+3,421,374New
FMR LLC2,316,907$775.68M0.03%+155,964+7.2%Added
BlackRock, Inc.2,292,585$767.53M0.01%−32,344−1.4%Reduced
PERCEPTIVE ADVISORS LLC2,035,986$681.63M10.58%00.0%Unchanged
BAKER BROS. ADVISORS LP1,753,198$586.95M2.94%00.0%Unchanged